Text Size

Effect of Pharmacist Initiated Recommendations On Prescribing For Participants In the Senior MEDS Personalized Medication Review

This study has been terminated.
(The program responsible for recruitment was dismantled in 2006.)
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00205140
First received: September 13, 2005
Last updated: July 2, 2008
Last verified: July 2008
History of Changes
  Purpose

What are the demographic and medication utilization characteristics of participants in the Senior MEDS personalized medication review compared to other community-dwelling elderly, what is the level of satisfaction with Senior Meds, and does the Senior Meds program lead to changes in the participants' drug regimen?


Condition
Healthy

Study Type: Observational
Official Title: Participant Characteristics, Medication Utilization, and the Effects of Pharmacist Initiated Recommendations On the Prescribing For Participants In the Senior MEDS Personalized Medication Review for Adults Age 55 and Older

Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment: 100
Study Start Date: July 2005
Estimated Study Completion Date: September 2006
  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 55 or older

Exclusion Criteria:

  • 54 or younger
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00205140

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Robert M Breslow, RPh, BCPS University of Wisconsin, Madison
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00205140     History of Changes
Other Study ID Numbers: M-2005-1166
Study First Received: September 13, 2005
Last Updated: July 2, 2008
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on May 23, 2013